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List of Abbreviations 
AFTER – Adjustment to Fear, Threat and Expectation of Recurrence 
FCR – Fear of Cancer Recurrence 
FCRI – Fear of Cancer Recurrence Inventory 
Mini-AFTERc – Mini-Adjustment to Fear, Threat and Expectation of Recurrence (cancer)  
NPI – Nottingham Prognostic Index 
SRM – Self-Regulation Model 
  
 Key Points 
 Aim was to test a single-session, telephone delivered intervention to reduce FCR in breast cancer 
patients.  
 16 female breast cancer patients received the 30-minute, Mini-Adjustment to the Fear, Threat and 
Expectation of Recurrence (Mini-AFTERc) intervention.  
 Intervention implementation was feasible with cancer nurse specialists and fidelity was high.  
 Participants showed a significant decrease in recurrence fears at follow-up (effect size = 0.8; p = 0.03).  
 Preliminary results suggest the Mini-AFTERc is effective in reducing recurrence fears in breast cancer 
survivors.  
  
Introduction 
One of the most prevalent concerns for cancer survivors is fear of cancer recurrence (FCR) [1],  defined as 
'the fear that cancer may return or progress in the same place or another part of the body'[2].  
Roughly half of all cancer survivors report moderate FCR and an intensive intervention may be 
counterproductive for these patients.  A short intervention used as part of routine care may be helpful to 
prevent FCR from increasing. 
The six-session AFTER intervention [3] has been adapted into a single-session intervention named the ‘Mini-
AFTERc’. This, 30 minute, single-session intervention is designed for patients with moderate FCR and for it 
to be incorporated into routine cancer care by specialist cancer nurses.  The intervention may assist 
patients with severe FCR, however the small duration and intensity may be insufficient. For higher FCR 
levels a multi-session intervention may be recommended e.g. [4]. The aim of this study was to conduct a 
small, feasibility study using the Mini-AFTERc intervention with breast cancer patients with moderate FCR. 
The objectives were to: (i) assess the feasibility of incorporating the intervention into routine care, (ii) 
evaluate the intervention effect and (iii) assess the fidelity to the intervention manual. 
 
Methods 
This study is single-site, repeated measures, and quasi-experimental.  Recruitment of 16 patients was 
considered sufficient.   Statistical power was over 80% from a change of pre- and post-Fear Cancer 
Recurrence Inventory-Severity (FCRIs) [5] of 4 scale units (SD of change = 6), assuming a correlation of 0.5 
between pre- and post-measures.  
 
Participants 
Participants were eligible for study inclusion if they had: past breast cancer diagnosis (stages 1-3);  
completed primary treatment, scored >13 on FCRIs (range: 0-36); and ineligible for inclusion if they had a 
current, major psychiatric disorder, or were unable to give informed consent or converse in English. All 
patients over the FCRIs cut-off were eligible for inclusion, including patients with ‘high’ FCR levels.  A 
referral line was created if patients required further assistance.  Participants attending routine follow-up 
were recruited either face-to-face, by letter or telephone, from the current breast cancer centre patient 
list. All interventions were conducted within 4 weeks of baseline.  Participants were contacted for follow-up 
1 week post-intervention. The Mini-AFTERc intervention was delivered by three Clinical Nurse Specialists, 
who had an average of 15 years’ experience. Five training worksite meetings on the Mini-AFTERc lasting 90 
minutes each were conducted by the senior author with source book for supporting standard cognitive 
behavioural methods [6].  Ethical approval was granted by local Research Ethics Committee (ref: 
LR/14/ES/0035).   
 
Outcomes 
The primary outcome was feasibility of the study and the intervention. Secondary outcomes included 
efficacy of the intervention at reducing FCR and intervention fidelity.  
 
Measures 
Feasibility was assessed by recruitment uptake and drop-out rates. Incorporation into care system was 
assessed via short interviews with the nursing staff.  The 9 item FCRIs was administered at baseline and 1-
week post-intervention. Patients rate the affect, issue frequency and cognitions regarding FCR on a Likert-
type scale from 0 ('not at all' or 'never') to 4 ('a great deal' or 'all of the time'). High scores indicate greater 
severity (possible range 0-36).  Fidelity was measured by analysing consultation audio recordings and 
checking correspondence to the instruction manual.  Demographic information including age, gender, 
marital status, cancer type, time since completion of primary treatment, treatment method and cancer 
prognosis (Nottingham Prognostic Index: NPI) was collected at baseline.  
 
The Mini-AFTERc Intervention is based upon cognitive behavioural principles (Leventhal’s self-regulation 
model) [7]. The intervention targets recurrence fears, inappropriate or excessive checking behaviours and 
general cancer beliefs. The Mini-AFTERc is designed to normalise the presence of these fears, without 
reducing the importance of vigilance in symptom change and appropriate self-checking.  
 
The Mini-AFTERc intervention comprises 5 primary topics:  
1. Assessment – introduction of topics (2-5) and identification of which require detailed 
discussion. 
2. Family – discussion of issues surrounding the role family plays in their recovery from 
cancer, identifying supportive or antagonistic behaviour.   
3. Thoughts and Feelings – identification and discussion of symptoms and experiences related 
by patient experiences and associated cognitions.   
4. Expectation – discussion of attendance at outpatient clinics and self-examination 
behaviours.   
5. Return of cancer – discussion of recurrence specific cognitions and thoughts about the 
future. 
 
Data Analysis 
A generalised linear model (Gaussian distribution) using a robust maximum likelihood estimator was 
applied with time (pre, post) as a between subjects factor, controlling for age and prognosis (NPI).  Linear 
regression analyses were conducted using demographic and medical characteristics as predictor variables 
with change in FCRI score as the criterion. Statistics were calculated using STATAv13 [8] with 5% alpha level 
(2 sided).  
 
 
Results 
 
A total of 16 participants completed the intervention. Sociodemographic and medical characteristics of the 
sample are presented in Table 1. No participants dropped out during the course of the study. 
 
Feasibility 
Over 3 months, 102 women were screened for eligibility and provided with baseline questionnaires; 66 
women completed and returned the questionnaire. Of these, 23 did not meet the criterion score on the 
FCRI (14) and were not enrolled in the study. Of the remaining 43 patients we approached the first 18 
consecutively for invitation to participate. 2 participants declined participation, due to illness (n=1) and 
inability to commit to time demands (n=1). The remaining 25 patients were not approached due to limited 
resources available. Baseline FCR level for all screened participants was 17.66 (n=66).  
Nursing staff conducting the intervention deemed it useful and believed that it may reduce demands by 
patients with FCR on health service time and resources. They found the intervention layout to be easy to 
understand, follow and apply.  They recommended the manual would benefit from additional example 
questions related to common patient concerns. Patients commented the intervention to be helpful and 
were pleased to have participated.  
 
Changes in Fear of Cancer Recurrence 
The FCR of 12 patients decreased from baseline to 1 week follow-up (Table 1).  Results of the general linear 
model indicate a significant effect of time on FCR: coefficient = -4.21, robust standard error = 2.01, p = 
0.032.  Exploratory regression analyses showed that the variables: baseline FCR level, demographic, medical 
characteristics or nurse conducting the intervention were not predictive of FCR change.  
 
Fidelity 
Audio tapes were available from 12 consultations (four missing for technical reasons).  Calls lasted between 
11 and 43 minutes (mean = 25).  Average fidelity score across all evaluated sessions was 20.4 (out of 
possible 24); an 85% adherence to the intervention guidelines.   
 
Discussion 
 
Findings of this feasibility study suggested that the single-session Mini AFTER intervention is effective at 
reducing FCR in breast cancer survivors. Furthermore, this improvement was not associated with initial 
score of participants’ FCR, their demographic or medical characteristics. Effect size for FCR change was 
relatively large (above 0.8)[9]. These initial results were promising.  
 
Mean change in FCRI score (4.3) supports the principle of the Mini-AFTER intervention in that it could be 
beneficial to patients with moderate FCR. However a 4 unit reduction is likely not sufficient for patients 
with more severe recurrence fears, thus more intensive interventions of greater duration may be required. 
Implementation of the intervention and the study proved feasible.  Some improvements to the manual 
were recommended including more examples.  Additionally, staff did not feel the intervention placed a high 
demand on time, capability or financial resources, in fact they felt it may have the potential to lessen 
patient demand. A separate funded study will report on a more extended investigation of acceptability in 
specialist cancer nurses in the UK.  Baseline FCR level for all screened breast cancer patients (17.7) was 
slightly higher than previous reports (14.3) [5].  Recruitment and attrition rates also supported the 
feasibility of the intervention in out-patient services. None of the recruited participants dropped-out from 
baseline and all completed follow-up.   
 
The fidelity high scores indicated that the nursing staff were able to implement the intervention. It also 
suggests that the nurses could direct the flow of a therapeutic interaction to cover the large majority of 
requisite topics. However, low scores on the ‘Symptom’ topic were noted. Generally the staff were 
instructed to try and not get wrapped up in a medical assessment as is their primary training. As a 
consequence they may have over-compensated and not adequately discussed topics of a more medical 
nature. However, the generally positive results indicate that the initial training, supervision and the written 
Mini AFTER manual is relatively straightforward to implement.  The high agreement in fidelity rating was 
reassuring. 
 
There were some limitations. Most notably, this included low sample size. The intervention was not 
effective for every patient, change scores ranged from -20 to 8 (negative scores indicating a decrease in 
FCR; an improvement).  Two patients whose FCR increased at follow-up had co-morbid issues (alcohol 
dependence and recent bereavement).  These results should be viewed with caution due to the possibility 
of patients responding to demand characteristics. The follow-up was short.   The present study provides a 
foundation for future research investigating this intervention through increased sample size, 
randomisation, longer follow up and use of a control condition.   
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Table 1. Participants’ demographic and medical characteristics (N= 16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FCRI: Fear of Cancer Recurrence Inventory-Severity Subscale [5] 
* p < 0.05  
 
 
 
 
 
 
 
 
 
 
 
  
M (SD) 
Age in years 60 (11.7) 
Time Since Treatment  in months 10.1 (5.9) 
Nottingham Prognostic Index (NPI) 3.7 (0.9) 
  
            Percentage        (N) 
Gender:  
Female 100          (16) 
 
Cancer Type:  
Breast 100          (16) 
 
Marital Status:  
Single 12.5              (2) 
Married 68.75          (11) 
Widowed 18.75            (3) 
  
FCRI:  
 (pre)  24.8 (4.48)  
(post)* 20.5 (7.13) 
Fear of Cancer Recurrence 
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